
Subcutaneous Pembrolizumab Matches IV in Lung Cancer Trial
In an interview with Pharmacy Times®, Enriqueta Felip, MD, PhD, medical oncologist at Vall d'Hebron Hospital in Barcelona, Spain, shared findings from the MK-3475A-D77 trial (NCT05722015) evaluating the pharmacokinetics (PK) and safety of subcutaneous …